Author:
Villiger Ralph,Bogdan Boris
Publisher
Springer Science and Business Media LLC
Subject
Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology
Reference5 articles.
1. Fernández, P. Valuing real options: frequently made errors. Journal of Financial Transformations, 13, 77–81 (2005).
2. Dimasi, J.A. Risks in new drug development: approval success rates for investigational drugs. Clin. Pharmacol. Ther. 69, 297–307 (2001).
3. Kola, I. & Landis, J. Can the pharmaceutical industry reduce attrition rates? Nat. Rev. Drug Discov. 3, 711–715 (2004).
4. Tufts Center for the Study of Drug Development. Outlook 2005. Tufts Outlook Report. (Tufts Center, Medford, MA, USA, 2005).
5. Grabowski, H.G. & Vernon, J. The distribution of sales revenues from pharmaceutical innovation. Pharmacoeconomics 18 Suppl 1, 21–32 (2000).
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献